• Here’s what brokers tip for WiseTech shares over the next 12 months

    A woman with her hands over her face splits her fingers over one eye so she can peep through it.

    WiseTech Global Ltd (ASX: WTC) shares have slipped even further into the red in Wednesday morning trade.

    At the time of writing, the shares are down around 2% to $33.24.

    Today’s decline means they’re now down around 51% year to date and a huge 72% below the trading levels seen this time last year.

    It’s been a steep and sustained share price crash for WiseTech shares, driven mostly by a tech-sector-wide sell-off and an investor rotation to more stable assets amid global volatility earlier this year. 

    Recent headwinds from following media reports that the Australian Federal Police is investigating founder Richard White over alleged trafficking matters haven’t helped investor confidence.

    The company responded that the alleged investigation concerns Richard White in a personal capacity. It added that there is no suggestion in this media commentary of an investigation into WiseTech. But it didn’t stop investors rushing for the exit. 

    The question now is: Can WiseTech shares keep crashing lower? Or is it time to buy the stock while it’s trading for cheap?

    Here’s what the experts expect from the tech company over the next 12 months.

    Buy, sell, or hold: Here’s what brokers tip for WiseTech shares

    Despite the crashing share price, it looks like analyst sentiment around WiseTech shares has barely shifted over the past few months. However, some price forecasts have been cut.

    Market Index data still shows the majority of brokers have a buy rating on the tech stock. At the time of writing, the $70.84 average target price implies a potential 112% upside over the next 12 months.

    TradingView data shows something similar. Out of 14 analysts, 11 have a buy or strong buy rating on WiseTech shares. Another three have a hold rating. 

    Their average target price is lower, at $62.75, but that still implies a potential 88% upside, at the time of writing. The more bullish analysts are tipping an enormous 246% upside to a maximum target price of $115.31.

    Citi is one bullish broker that anticipates a strong recovery for WiseTech shares. The broker renewed its buy rating earlier this month but cut its 12-month target significantly to $52, down from $65.65 previously.

    Bell Potter also has a buy rating on the ASX 200 tech share, and a 12-month target price of $71.75. The broker said there has been a tech rally of sorts on the ASX over the past couple of months, but that WiseTech has missed out, likely due to a number of headwinds that have put investors off. The broker said, however, these negatives will start to dissipate over the coming months, starting with the recent appointment of Raelene Murphy as Chair.

    My view on the ASX tech shares

    I think WiseTech’s future hinges on its FY26 results next month. 

    The company reaffirmed its FY26 guidance earlier this year, expecting full-year revenue of US$1.39 billion to US$1.44 billion (representing a 79% to 85% increase) and EBITDA in the range of US$550 million to US$585 million, up 44% to 53% from FY25.

    If WiseTech manages to reach or exceed its upgraded guidance, I think we’ll see a turnaround in the share price.

    The post Here’s what brokers tip for WiseTech shares over the next 12 months appeared first on The Motley Fool Australia.

    Should you invest $1,000 in WiseTech Global right now?

    Before you buy WiseTech Global shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and WiseTech Global wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Up 1,511% in a year, guess which ASX uranium share is storming higher again on Wednesday

    Rocket going up above mountains, symbolising a record high.

    ASX uranium share Cauldron Energy Ltd (ASX: CXU) is at it again.

    And by ‘it’, I mean rocketing higher.

    Cauldron Energy shares closed yesterday trading for 13 cents. In late morning trade on Wednesday, shares are changing hands for 14.5 cents apiece, up 11.5%.

    For some context, the S&P/ASX Small Ordinaries Index (ASX: XSO) is up 0.6% at this same time.

    With today’s intraday gains factored in, the junior ASX uranium share cements its place as a 10-bagger-plus. (That’s a stock that returns at least 10-times your original investment within a relatively modest time frame.)

    Indeed, 12 months ago, you could have picked up Cauldron Energy shares for just 0.9 cents each. Meaning the stock has gained a jaw-dropping 1,511.1%.

    Or enough to turn a $10,000 investment into $161,111.

    In one year!

    The miner has been benefiting from a series of exploration successes and strategic acquisitions, along with rising uranium prices.

    Now, here’s what’s stoking ASX investor interest again today.

    ASX uranium share jumps on drill results

    The Cauldron Energy share price is rocketing following an update on the company’s Yanrey Uranium Project, located in Western Australia.

    The ASX uranium share revealed that the results it just received for the first 14 drill holes of its 2026 drill campaign have returned high-grade uranium results at the Manyingee North Deposit, within Yanrey.

    Manyingee North was earlier reported to host an existing Inferred Mineral Resource Estimate of 14.9 million tonnes containing 9.8 million pounds of uranium at an average grade of 297 ppm eU3O8 (equivalent uranium oxide).

    Cauldron CEO Jonathan Fisher noted that the start of the company’s drill campaign was “slightly delayed due to weather and a little slow to ramp up due to some minor technical issues (now resolved), which led us being a little later than we initially expected in getting these first results out”.

    Top results from one of the drill holes included:

    • 30 metres at 258.3 ppm eU3O8 from 91.62 metres
    • 70 metres at 243.0 ppm eU3O8 from 94.42 metres

    What did Cauldron Energy management say?

    Commenting on the successful 2026 drill program launch that’s boosting the ASX uranium share today, Fisher said:

    The program is now humming and from a results perspective, it’s been a great start to the 2026 drill program with all holes drilled at Manyingee North returning mineralisation, extended the mineralisation north and south to around 4 kilometres of strike, with mineralisation remaining open in all directions.

    Looking ahead, Fished added:

    With the extraordinary global macro thematic and all the positive news recently around the Australia India uranium arrangements and what that might possibly mean for the need to lift state restrictions and build new mines to satisfy demand, it’s a great time to be out drilling and demonstrating the prolific nature and scale of the uranium project at Yanrey.

    We will keep the rig spinning and look forward to reporting the next set of results!

    The post Up 1,511% in a year, guess which ASX uranium share is storming higher again on Wednesday appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Cauldron Energy right now?

    Before you buy Cauldron Energy shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Cauldron Energy wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Up over 1,000%: Can the best-performing stocks on the ASX 200 keep rising?

    Woman looks amazed and shocked as she looks at her laptop.

    The S&P/ASX 200 Index (ASX: XJO) has had a choppy time over the past 12 months as global volatility, share market uncertainty, interest rate stress, and fickle investors saw shares across the index swing wildly.

    At the time of writing, the ASX 200 Index is just over 0.5% higher year to date and around 1% higher than 12 months ago.

    Around half of the shares on the index are now trading lower than they were 12 months ago. But, on the flip side, there are some standout performers that have roared higher over the past year.

    4DMedical Ltd (ASX: 4DX) and Sunrise Energy Metals Ltd (ASX: SRL) shares have each risen by more than 1,000% over the past 12 months. 

    Find out if they can keep climbing higher.

    Are 4DMedical shares a buy, sell, or hold?

    4DMedical shares have risen 1,215% over the past 12 months and are trading at $3.42 a piece at the time of writing. The ASX healthcare business is the strongest performer on the ASX 200 Index over the past 12 months.

    The company saw its share price explode in 2025 after its flagship product, CT:VQ, received regulatory approvals. It was quickly implemented and adopted through various contracts and partnerships with major hospitals and medical providers, primarily across the US. 

    The leap in development and fast adoption means 4DMedical moved very quickly from a research and development business to a globally commercial business.

    The share price peaked at an all-time high of $6.80 a piece in April this year. This was when the company joined the ASX 200 Index. 

    But the shares quickly shed around 50% after a broad sell-off of ASX 200 healthcare stocks drove many shares across the sector to low levels. It’s also likely that many investors rushed to take their gains off the table after an incredible run-up.

    Since then, the shares have been relatively flat as investors try to work out whether the business has the potential to keep growing.

    4D Medical is still in its growth phase and is working to expand its commercial footprint further. Approvals have been secured in Canada and New Zealand. The company is now actively progressing commercialisation plans in Europe and Australia.

    It looks like analysts are divided about the outlook for the shares.

    TradingView data shows three analysts are split between strong buy, hold, and strong sell ratings. A $4.97 target price implies a 45% upside at the time of writing. But some think the shares have the potential to jump 75% to $6 a piece over the next 12 months.

    Are Sunrise Energy shares a buy, sell, or hold?

    Sunrise Energy is not officially a member of the ASX 200. But the company currently ranks in 194th place across all ASX-listed companies (out of 2,336) based on its market capitalisation of $2.4 billion.

    Sunrise Energy develops huge mining and mineral processing projects. Essentially, the company develops and manages the application of ion-exchange technology. This technology is used to extract valuable metals for the mining industry and to purify and recycle wastewater.

    The Australian minerals company is also developing one of the world’s largest and highest-grade primary scandium and nickel-cobalt deposits. Its flagship operation is the Syerston Project in central-west NSW.

    This exposure gives Sunrise Energy a unique position in an emerging market where demand is booming, but there aren’t many credible suppliers. 

    Over the past 12 months, Sunrise Energy shares have climbed by over 1,050%. The shares are trading at $15.42 a piece at the time of writing. The increase has been relatively consistent over that period, too.

    The share price spiked at $18.59 in late June and has cooled slightly since then, most likely due to investors taking gains off the table after the huge rally. 

    The challenge for investors is that analyst coverage on the stock is limited. TradingView data shows that only one broker currently covers Sunrise Energy. However, that broker has a strong buy rating and a $20 target price on the shares. At the time of writing, that implies a potential 30% upside over the next 12 months.

    The post Up over 1,000%: Can the best-performing stocks on the ASX 200 keep rising? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in 4DMedical right now?

    Before you buy 4DMedical shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 4DMedical wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 16 June 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Sorry, but nothing was found. Please try a search with different keywords.